Invesco’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-39,106
| Closed | -$1.5M | – | 3934 |
|
2023
Q2 | $1.5M | Buy |
39,106
+1,368
| +4% | +$52.6K | ﹤0.01% | 2720 |
|
2023
Q1 | $874K | Sell |
37,738
-170,794
| -82% | -$3.95M | ﹤0.01% | 2945 |
|
2022
Q4 | $5.46M | Buy |
208,532
+13,422
| +7% | +$352K | ﹤0.01% | 2199 |
|
2022
Q3 | $3.84M | Sell |
195,110
-151,544
| -44% | -$2.98M | ﹤0.01% | 2347 |
|
2022
Q2 | $6.06M | Buy |
346,654
+315,755
| +1,022% | +$5.52M | ﹤0.01% | 2169 |
|
2022
Q1 | $506K | Buy |
30,899
+19,852
| +180% | +$325K | ﹤0.01% | 3349 |
|
2021
Q4 | $180K | Sell |
11,047
-945
| -8% | -$15.4K | ﹤0.01% | 3771 |
|
2021
Q3 | $153K | Buy |
11,992
+1,512
| +14% | +$19.3K | ﹤0.01% | 3833 |
|
2021
Q2 | $148K | Buy |
+10,480
| New | +$148K | ﹤0.01% | 3812 |
|
2020
Q1 | – | Sell |
-10,867
| Closed | -$64K | – | 3696 |
|
2019
Q4 | $64K | Sell |
10,867
-720
| -6% | -$4.24K | ﹤0.01% | 3573 |
|
2019
Q3 | $61K | Sell |
11,587
-460
| -4% | -$2.42K | ﹤0.01% | 3592 |
|
2019
Q2 | $93K | Sell |
12,047
-414
| -3% | -$3.2K | ﹤0.01% | 3637 |
|
2019
Q1 | $248K | Buy |
+12,461
| New | +$248K | ﹤0.01% | 3532 |
|
2016
Q3 | – | Sell |
-10,127
| Closed | -$573K | – | 3659 |
|
2016
Q2 | $573K | Buy |
+10,127
| New | +$573K | ﹤0.01% | 3174 |
|
2015
Q3 | – | Sell |
-30
| Closed | -$5K | – | 4026 |
|
2015
Q2 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 4233 |
|